BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy9139
(197 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2NZI|A Chain A, Crystal Structure Of Domains A168-A170 From Titin
pdb|2NZI|B Chain B, Crystal Structure Of Domains A168-A170 From Titin
Length = 305
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 40/128 (31%), Positives = 61/128 (47%), Gaps = 4/128 (3%)
Query: 3 GNYTCLADNIFGKDDIYYQVTILSPPGVPN-ILLQSTTTHSISILW-KPSYDGGAIITHY 60
G Y A N FG D ++ + P P + + + S+++ W +P+ DGG+ IT+Y
Sbjct: 174 GFYVVCAKNRFGIDQKTVELDVADVPDPPRGVKVSDVSRDSVNLTWTEPASDGGSKITNY 233
Query: 61 IVSYRDRT-EDWQSVHVDAEYREFTLTQLKCGTHYKINIKLVNSIGESKPSKTIAASTKG 119
IV T E W V E R +T+ L T Y+ + N G SKPS+ +
Sbjct: 234 IVEKCATTAERWLRVGQARETR-YTVINLFGKTSYQFRVIAENKFGLSKPSEPSEPTITK 292
Query: 120 EDQTDWIN 127
ED+T +N
Sbjct: 293 EDKTRAMN 300
>pdb|2EDB|A Chain A, Solution Structure Of The Fourth Fibronectin Type Iii
Domain Of Human Netrin Receptor Dcc
Length = 116
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 44/82 (53%)
Query: 28 PGVPNILLQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTEDWQSVHVDAEYREFTLTQ 87
P P+ L T+ I + W P + ++ YI+ Y + ++V VD++ R +++ +
Sbjct: 18 PDQPSSLHVRPQTNCIIMSWTPPLNPNIVVRGYIIGYGVGSPYAETVRVDSKQRYYSIER 77
Query: 88 LKCGTHYKINIKLVNSIGESKP 109
L+ +HY I++K N+ GE P
Sbjct: 78 LESSSHYVISLKAFNNAGEGVP 99
>pdb|3LPW|A Chain A, Crystal Structure Of The Fniii-Tandem A77-A78 From The
A-Band Of Titin
pdb|3LPW|B Chain B, Crystal Structure Of The Fniii-Tandem A77-A78 From The
A-Band Of Titin
Length = 197
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 41/86 (47%), Gaps = 3/86 (3%)
Query: 27 PPGVPNILLQSTTTHSISILW-KPSYDGGAIITHYIVSYRDRTEDWQSVHVDAEYREFTL 85
PPG I L T +S+S+ W KP +DGG+ I YIV + + D + + E T+
Sbjct: 105 PPG--KITLMDVTRNSVSLSWEKPEHDGGSRILGYIVEMQTKGSDKWATCATVKVTEATI 162
Query: 86 TQLKCGTHYKINIKLVNSIGESKPSK 111
T L G Y + N G S P +
Sbjct: 163 TGLIQGEEYSFRVSAQNEKGISDPRQ 188
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 4/98 (4%)
Query: 28 PGVPNIL-LQSTTTHSISILWKPSY-DGGAIITHYIVSYRDRTED-WQSVHVDAEYREFT 84
PG P L ++ T S+++ W P DGG+ I +YIV R+ T + +V + +
Sbjct: 6 PGPPQDLKVKEVTKTSVTLTWDPPLLDGGSKIKNYIVEKRESTRKAYSTVATNCHKTSWK 65
Query: 85 LTQLKCGTHYKINIKLVNSIGESKPSKTIAASTKGEDQ 122
+ QL+ G Y + N G P++T A S K ++
Sbjct: 66 VDQLQEGCSYYFRVLAENEYGIGLPAET-AESVKASER 102
>pdb|1X5I|A Chain A, The Solution Structure Of The Fourth Fibronectin Type Iii
Domain Of Human Neogenin
Length = 126
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 40/82 (48%)
Query: 28 PGVPNILLQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTEDWQSVHVDAEYREFTLTQ 87
P VP+ L SI + W P + ++ Y + Y + Q++ VD + R +T+
Sbjct: 28 PEVPSSLHVRPLVTSIVVSWTPPENQNIVVRGYAIGYGIGSPHAQTIKVDYKQRYYTIEN 87
Query: 88 LKCGTHYKINIKLVNSIGESKP 109
L +HY I +K N++GE P
Sbjct: 88 LDPSSHYVITLKAFNNVGEGIP 109
>pdb|1X4Z|A Chain A, Solution Structure Of The 2nd Fibronectin Type Iii Domain
From Mouse Biregional Cell Adhesion
Molecule-RelatedDOWN- Regulated Oncogenes (Cdon) Binding
Protein
Length = 121
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 5/91 (5%)
Query: 25 LSPPGVPNILLQSTTTH-SISILWKPSYDGGAIITHYIVSYRD--RTEDW--QSVHVDAE 79
LSPP P+ ST + S+ + W P +GG I + V Y+ + DW + +
Sbjct: 15 LSPPEAPDRPTISTASETSVYVTWIPRGNGGFPIQSFRVEYKKLKKVGDWILATSAIPPS 74
Query: 80 YREFTLTQLKCGTHYKINIKLVNSIGESKPS 110
+T L+ G YK ++ +N +GES+PS
Sbjct: 75 RLSVEITGLEKGISYKFRVRALNMLGESEPS 105
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 43.9 bits (102), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 26 SPPGVPNILLQSTTTHSISILWKP-SYDGGAIITHYIVSYRDRTEDWQSVHVDAEYREFT 84
PP P ++++ ++ + WKP + DGG+++T+Y + R+ S + Y T
Sbjct: 11 EPPRFP--IIENILDEAVILSWKPPALDGGSLVTNYTIEKREAMGGSWSPCAKSRYTYTT 68
Query: 85 LTQLKCGTHYKINIKLVNSIGESKPSKTIA 114
+ L+ G Y+ I N G+SKP + A
Sbjct: 69 IEGLRAGKQYEFRIIAENKHGQSKPCEPTA 98
>pdb|2JLL|A Chain A, Crystal Structure Of Ncam2 Igiv-Fn3ii
Length = 389
Score = 43.9 bits (102), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 2/93 (2%)
Query: 20 YQVTILSPPGVPNILLQSTTTHSISILWKPSYDGGAIITHYIVSYR--DRTEDWQSVHVD 77
+Q + P P+I Q ++ S + DGGA I YIV YR D+ + W V
Sbjct: 286 FQTLPVREPSPPSIHGQPSSGKSFKLSITKQDDGGAPILEYIVKYRSKDKEDQWLEKKVQ 345
Query: 78 AEYREFTLTQLKCGTHYKINIKLVNSIGESKPS 110
L L+ Y++ I N +G S+P+
Sbjct: 346 GNKDHIILEHLQWTMGYEVQITAANRLGYSEPT 378
Score = 40.0 bits (92), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 47/113 (41%), Gaps = 5/113 (4%)
Query: 3 GNYTCLADNIFGKDDIYYQVTILSPPGVP---NILLQSTTTHSISILWKPSYDGGAIITH 59
G Y C A N G Y + + P P I+ S TT +S KP GG I H
Sbjct: 171 GRYNCTATNHIGTRFQEYILALADVPSSPYGVKIIELSQTTAKVS-FNKPDSHGGVPIHH 229
Query: 60 YIVSYRD-RTEDWQSVHVDAEYREFTLTQLKCGTHYKINIKLVNSIGESKPSK 111
Y V ++ +E W+ V L L+ T Y+I + VN G+ SK
Sbjct: 230 YQVDVKEVASEIWKIVRSHGVQTMVVLNNLEPNTTYEIRVAAVNGKGQGDYSK 282
>pdb|2KBG|A Chain A, Solution Structure Of The Second Fibronectin Type-Iii
Module Of Ncam2
Length = 114
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 39/88 (44%), Gaps = 2/88 (2%)
Query: 25 LSPPGVPNILLQSTTTHSISILWKPSYDGGAIITHYIVSYR--DRTEDWQSVHVDAEYRE 82
+ P P+I Q ++ S + DGGA I YIV YR D+ + W V
Sbjct: 6 MREPSPPSIHGQPSSGKSFKLSITKQDDGGAPILEYIVKYRSKDKEDQWLEKKVQGNKDH 65
Query: 83 FTLTQLKCGTHYKINIKLVNSIGESKPS 110
L L+ Y++ I N +G S+P+
Sbjct: 66 IILEHLQWTMGYEVQITAANRLGYSEPT 93
>pdb|1BPV|A Chain A, Titin Module A71 From Human Cardiac Muscle, Nmr, 50
Structures
Length = 112
Score = 40.4 bits (93), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 25 LSPPGVPNILLQSTTTHSISILW-KPSYDGGAIITHYIVSYRDRTED-WQSVHV-DAEYR 81
+ PPG P L + T H++++ W KP Y GG IT YIV RD W + +
Sbjct: 11 IDPPGKPVPL--NITRHTVTLKWAKPEYTGGFKITSYIVEKRDLPNGRWLKANFSNILEN 68
Query: 82 EFTLTQLKCGTHYKINIKLVNSIGE-SKPSKTIAASTKGED 121
EFT++ L Y+ + N+ G S PS+ A T +D
Sbjct: 69 EFTVSGLTEDAAYEFRVIAKNAAGAISPPSEPSDAITCRDD 109
>pdb|2XYC|A Chain A, Crystal Structure Of Ncam2 Igiv-Fn3i
Length = 291
Score = 40.4 bits (93), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 47/113 (41%), Gaps = 5/113 (4%)
Query: 3 GNYTCLADNIFGKDDIYYQVTILSPPGVP---NILLQSTTTHSISILWKPSYDGGAIITH 59
G Y C A N G Y + + P P I+ S TT +S KP GG I H
Sbjct: 171 GRYNCTATNHIGTRFQEYILALADVPSSPYGVKIIELSQTTAKVS-FNKPDSHGGVPIHH 229
Query: 60 YIVSYRD-RTEDWQSVHVDAEYREFTLTQLKCGTHYKINIKLVNSIGESKPSK 111
Y V ++ +E W+ V L L+ T Y+I + VN G+ SK
Sbjct: 230 YQVDVKEVASEIWKIVRSHGVQTMVVLNNLEPNTTYEIRVAAVNGKGQGDYSK 282
>pdb|2CRM|A Chain A, Solution Structure Of The Forth Fniii Domain Of Human
Length = 120
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/109 (25%), Positives = 48/109 (44%), Gaps = 6/109 (5%)
Query: 14 GKDDIYYQVTILSPPGVP--NILLQSTTTHSISILWKPSYD-GGAIITHYIVSYRDRTE- 69
G + T PG+P + +HS I W P D GGA I Y+V + +
Sbjct: 4 GSSGVVEFTTCPDKPGIPVKPSVKGKIHSHSFKITWDPPKDNGGATINKYVVEMAEGSNG 63
Query: 70 -DWQSVHVDAEYREFTLTQLKCGTHYKINIKLVNSIGESKPSKTIAAST 117
W+ ++ A RE +L G Y++ + ++ G+S S+++ T
Sbjct: 64 NKWEMIYSGAT-REHLCDRLNPGCFYRLRVYCISDGGQSAVSESLLVQT 111
>pdb|2YUW|A Chain A, Solution Structure Of 2nd Fibronectin Domain Of Slow Type
Myosin-Binding Protein C
Length = 110
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 43/80 (53%), Gaps = 3/80 (3%)
Query: 33 ILLQSTTTHSISILWKP-SYDGGAIITHYIVSY-RDRTEDWQSVHVDA-EYREFTLTQLK 89
+ + S T ++++ W+P + G A + Y++ Y + TEDW + D + +FT+T L
Sbjct: 14 LTVDSVTDTTVTMRWRPPDHIGAAGLDGYVLEYCFEGTEDWIVANKDLIDKTKFTITGLP 73
Query: 90 CGTHYKINIKLVNSIGESKP 109
+ +K VN+ G S+P
Sbjct: 74 TDAKIFVRVKAVNAAGASEP 93
>pdb|3LOH|E Chain E, Structure Of The Insulin Receptor Ectodomain, Including Ct
P
Length = 917
Score = 37.0 bits (84), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 1/65 (1%)
Query: 14 GKDDIYYQVTILSPPGVP-NILLQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTEDWQ 72
K DI Y T + P VP + + S ++ I + WKP D ITHY+V + + ED +
Sbjct: 581 AKSDIIYVQTDATNPSVPLDPISVSNSSSQIILKWKPPSDPNGNITHYLVFWERQAEDSE 640
Query: 73 SVHVD 77
+D
Sbjct: 641 LFELD 645
>pdb|2DTG|E Chain E, Insulin Receptor (Ir) Ectodomain In Complex With Fab's
Length = 897
Score = 37.0 bits (84), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 1/65 (1%)
Query: 14 GKDDIYYQVTILSPPGVP-NILLQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTEDWQ 72
K DI Y T + P VP + + S ++ I + WKP D ITHY+V + + ED +
Sbjct: 581 AKSDIIYVQTDATNPSVPLDPISVSNSSSQIILKWKPPSDPNGNITHYLVFWERQAEDSE 640
Query: 73 SVHVD 77
+D
Sbjct: 641 LFELD 645
>pdb|3MTR|A Chain A, Crystal Structure Of The Ig5-Fn1 Tandem Of Human Ncam
pdb|3MTR|B Chain B, Crystal Structure Of The Ig5-Fn1 Tandem Of Human Ncam
Length = 215
Score = 36.2 bits (82), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 28/109 (25%), Positives = 46/109 (42%), Gaps = 6/109 (5%)
Query: 3 GNYTCLADNIFGKDDIYYQVTILSPPGVPNILLQSTTTHSISILW-KPSYDGGAIITHYI 61
GNY C A N G++ + + + P P+I + + + + +P GG I Y
Sbjct: 89 GNYNCTAVNRIGQESLEFILVQADTPSSPSIDQVEPYSSTAQVQFDEPEATGGVPILKYK 148
Query: 62 VSYRDRTED-WQSVHVDAEYREF----TLTQLKCGTHYKINIKLVNSIG 105
+R E+ W S DA+ T+ LK T Y + + +N G
Sbjct: 149 AEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKG 197
>pdb|2DJU|A Chain A, Solution Structures Of The Fn3 Domain Of Human Receptor-
Type Tyrosine-Protein Phosphatase F
Length = 106
Score = 34.3 bits (77), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 32 NILLQSTTTHSISILWKPSYDGG--AIITHYIVSYRDRTEDWQSVHVDA-EYREFTLTQL 88
++++ TT S+++ W D G +T+Y + YR + VD +++ L
Sbjct: 13 DLVVTETTATSVTLTW----DSGNSEPVTYYGIQYRAAGTEGPFQEVDGVATTRYSIGGL 68
Query: 89 KCGTHYKINIKLVNSIGESKPSKTIAAST 117
+ Y + VNSIG PS+ + A T
Sbjct: 69 SPFSEYAFRVLAVNSIGRGPPSEAVRART 97
>pdb|2DOC|A Chain A, Solution Structure Of The Fibronectin Type-Iii Domain Of
Human Neural Cell Adhesion Molecule 2
Length = 119
Score = 34.3 bits (77), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 31/87 (35%), Positives = 40/87 (45%), Gaps = 3/87 (3%)
Query: 26 SPPGVPNILLQSTTTHSISILWKPSYDGGAIITHYIVSYRD-RTEDWQSVHVDAEYREFT 84
SP GV I L S TT +S KP GG I HY V ++ +E W+ V
Sbjct: 20 SPYGVKIIEL-SQTTAKVS-FNKPDSHGGVPIHHYQVDVKEVASEIWKIVRSHGVQTMVV 77
Query: 85 LTQLKCGTHYKINIKLVNSIGESKPSK 111
L L+ T Y+I + VN G+ SK
Sbjct: 78 LNNLEPNTTYEIRVAAVNGKGQGDYSK 104
>pdb|1UEM|A Chain A, Solution Structure Of The First Fibronectin Type Iii
Domain Of Human Kiaa1568 Protein
Length = 117
Score = 33.9 bits (76), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 22/86 (25%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 27 PPGVPNILLQSTTTHSISILWKPSYDGGAIITHYIVSY--RDRTEDWQSVHVDAEYREFT 84
PP P + T +S+++ W+P G + YI+ + + WQ+V + +T
Sbjct: 18 PPSKPQVT--DVTKNSVTLSWQPGTPGTLPASAYIIEAFSQSVSNSWQTVANHVKTTLYT 75
Query: 85 LTQLKCGTHYKINIKLVNSIGESKPS 110
+ L+ T Y ++ +N G S PS
Sbjct: 76 VRGLRPNTIYLFMVRAINPQGLSDPS 101
>pdb|2VKW|A Chain A, Human Ncam, Fn3 Domains 1 And 2
pdb|2VKW|B Chain B, Human Ncam, Fn3 Domains 1 And 2
Length = 209
Score = 33.9 bits (76), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 17/58 (29%), Positives = 29/58 (50%), Gaps = 1/58 (1%)
Query: 52 DGGAIITHYIVSYRDRTEDWQ-SVHVDAEYREFTLTQLKCGTHYKINIKLVNSIGESK 108
DGG+ I HY+V YR + +W+ + + + L L Y++ + N G+SK
Sbjct: 135 DGGSPIRHYLVRYRALSSEWKPEIRLPSGSDHVMLKSLDWNAEYEVYVVAENQQGKSK 192
>pdb|2VKX|A Chain A, Human Ncam, Fn3 Domains 1 And 2, M610r Mutant
pdb|2VKX|B Chain B, Human Ncam, Fn3 Domains 1 And 2, M610r Mutant
pdb|2VKX|C Chain C, Human Ncam, Fn3 Domains 1 And 2, M610r Mutant
pdb|2VKX|D Chain D, Human Ncam, Fn3 Domains 1 And 2, M610r Mutant
pdb|2VKX|E Chain E, Human Ncam, Fn3 Domains 1 And 2, M610r Mutant
pdb|2VKX|F Chain F, Human Ncam, Fn3 Domains 1 And 2, M610r Mutant
Length = 209
Score = 33.5 bits (75), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 17/58 (29%), Positives = 29/58 (50%), Gaps = 1/58 (1%)
Query: 52 DGGAIITHYIVSYRDRTEDWQ-SVHVDAEYREFTLTQLKCGTHYKINIKLVNSIGESK 108
DGG+ I HY+V YR + +W+ + + + L L Y++ + N G+SK
Sbjct: 135 DGGSPIRHYLVRYRALSSEWKPEIRLPSGSDHVMLKSLDWNAEYEVYVVAENQQGKSK 192
>pdb|1WF5|A Chain A, Solution Structure Of The First Fn3 Domain Of Sidekick-2
Protein
Length = 121
Score = 33.5 bits (75), Expect = 0.084, Method: Compositional matrix adjust.
Identities = 20/86 (23%), Positives = 37/86 (43%), Gaps = 2/86 (2%)
Query: 28 PGVPNILLQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTEDWQSV--HVDAEYREFTL 85
P P L + +I++ W +DG + + YI+ + W + VD + T+
Sbjct: 21 PEHPVATLSTVERRAINLTWTKPFDGNSPLIRYILEMSENNAPWTVLLASVDPKATSVTV 80
Query: 86 TQLKCGTHYKINIKLVNSIGESKPSK 111
L Y+ + VN +G+ + SK
Sbjct: 81 KGLVPARSYQFRLCAVNDVGKGQFSK 106
>pdb|1X5L|A Chain A, Solution Structure Of The Second Fn3 Domain Of Eph
Receptor A8 Protein
Length = 111
Score = 33.5 bits (75), Expect = 0.085, Method: Compositional matrix adjust.
Identities = 21/77 (27%), Positives = 37/77 (48%), Gaps = 1/77 (1%)
Query: 42 SISILWKPSYDGGAIITHYIVSYRDRTEDWQSVH-VDAEYREFTLTQLKCGTHYKINIKL 100
S+S+LW+ II Y + Y ++ ++ QS + A T++ LK GT Y ++
Sbjct: 26 SVSLLWQEPEQPNGIILEYEIKYYEKDKEMQSYSTLKAVTTRATVSGLKPGTRYVFQVRA 85
Query: 101 VNSIGESKPSKTIAAST 117
S G + S+ + T
Sbjct: 86 RTSAGCGRFSQAMEVET 102
>pdb|1UEY|A Chain A, Solution Structure Of The First Fibronectin Type Iii
Domain Of Human Kiaa0343 Protein
Length = 127
Score = 33.5 bits (75), Expect = 0.086, Method: Compositional matrix adjust.
Identities = 23/73 (31%), Positives = 32/73 (43%), Gaps = 3/73 (4%)
Query: 42 SISILWKPSYDGGAIITHYIVSYRDRTEDWQSVHVDAEYREF-TLTQLKCGTH--YKINI 98
S+ + W P D + IT +I+ Y D H E T QL + Y +
Sbjct: 32 SVQLSWTPGDDNNSPITKFIIEYEDAMHKPGLWHHQTEVSGTQTTAQLNLSPYVNYSFRV 91
Query: 99 KLVNSIGESKPSK 111
VNSIG+S PS+
Sbjct: 92 MAVNSIGKSLPSE 104
>pdb|1LWR|A Chain A, Solution Structure Of The Ncam Fibronectin Type Iii Module
2
Length = 96
Score = 32.7 bits (73), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 17/58 (29%), Positives = 28/58 (48%), Gaps = 1/58 (1%)
Query: 52 DGGAIITHYIVSYRDRTEDWQ-SVHVDAEYREFTLTQLKCGTHYKINIKLVNSIGESK 108
DGG+ I HY+V YR +W+ + + + L L Y++ + N G+SK
Sbjct: 28 DGGSPIRHYLVKYRALASEWKPEIRLPSGSDHVMLKSLDWNAEYEVYVVAENQQGKSK 85
>pdb|2RJM|A Chain A, 3ig Structure Of Titin Domains I67-I69 E-To-A Mutated
Variant
Length = 284
Score = 32.7 bits (73), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 12/27 (44%), Positives = 16/27 (59%)
Query: 2 VGNYTCLADNIFGKDDIYYQVTILSPP 28
G YTC A N+ GKD Q+ + +PP
Sbjct: 73 AGQYTCYASNVAGKDSCSAQLGVQAPP 99
>pdb|1X5G|A Chain A, The Solution Structure Of The Second Fibronectin Type Iii
Domain Of Human Neogenin
Length = 116
Score = 32.3 bits (72), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 23/97 (23%), Positives = 40/97 (41%), Gaps = 1/97 (1%)
Query: 21 QVTILSPPGVPNILLQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTEDWQSVHVDAEY 80
Q + P PN+ + + SI++ W+ G I +Y + Y ++ D + VD
Sbjct: 12 QPEVQLPGPAPNLRAYAASPTSITVTWETPVSGNGEIQNYKLYYMEKGTDKEQ-DVDVSS 70
Query: 81 REFTLTQLKCGTHYKINIKLVNSIGESKPSKTIAAST 117
+T+ LK T Y + N G + +A T
Sbjct: 71 HSYTINGLKKYTEYSFRVVAYNKHGPGVSTPDVAVRT 107
>pdb|3B43|A Chain A, I-band Fragment I65-i70 From Titin
Length = 570
Score = 32.3 bits (72), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 12/27 (44%), Positives = 15/27 (55%)
Query: 2 VGNYTCLADNIFGKDDIYYQVTILSPP 28
G YTC A N+ GKD Q+ + PP
Sbjct: 265 AGQYTCYASNVAGKDSCSAQLGVQEPP 291
Score = 28.1 bits (61), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 16/68 (23%), Positives = 30/68 (44%), Gaps = 2/68 (2%)
Query: 2 VGNYTCLADNIFGKDDIYYQVTILSPPGVPNILLQSTTTHSISILWKPSYDGGAIITHYI 61
+G Y C A N G D +T+ +PP L +T + + + +G I+ +
Sbjct: 452 IGEYQCKASNDVGSDTCVGSITLKAPPRFVKKLSDISTVVGEEVQLQATIEGAEPIS--V 509
Query: 62 VSYRDRTE 69
++D+ E
Sbjct: 510 AWFKDKGE 517
>pdb|2RIK|A Chain A, I-Band Fragment I67-I69 From Titin
Length = 284
Score = 32.0 bits (71), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 12/27 (44%), Positives = 15/27 (55%)
Query: 2 VGNYTCLADNIFGKDDIYYQVTILSPP 28
G YTC A N+ GKD Q+ + PP
Sbjct: 73 AGQYTCYASNVAGKDSCSAQLGVQEPP 99
>pdb|1X3D|A Chain A, Solution Structure Of The Fibronectin Type-Iii Domain Of
Human Fibronectin Type-Iii Domain Containing Protein 3a
Length = 118
Score = 30.8 bits (68), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 21/100 (21%), Positives = 45/100 (45%), Gaps = 2/100 (2%)
Query: 22 VTILSPPGVPNI-LLQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTEDWQSVHV-DAE 79
T+ P +PN + + T +S+++ WK D G+ I ++++ + + + +
Sbjct: 12 TTLSCEPDIPNPPRIANRTKNSLTLQWKAPSDNGSKIQNFVLEWDEGKGNGEFCQCYMGS 71
Query: 80 YREFTLTQLKCGTHYKINIKLVNSIGESKPSKTIAASTKG 119
++F +T+L K + N G S S+ + T G
Sbjct: 72 QKQFKITKLSPAMGCKFRLSARNDYGTSGFSEEVLYYTSG 111
>pdb|3R8Q|A Chain A, Structure Of Fibronectin Domain 12-14
Length = 290
Score = 30.8 bits (68), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 38/80 (47%), Gaps = 5/80 (6%)
Query: 32 NILLQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTEDWQSV--HVDAEYREFTLTQLK 89
N+ +TT +S+ + W+P A IT YI+ Y + V E T+T L+
Sbjct: 207 NLRFLATTPNSLLVSWQPPR---ARITGYIIKYEKPGSPPREVVPRPRPGVTEATITGLE 263
Query: 90 CGTHYKINIKLVNSIGESKP 109
GT Y I + + + +S+P
Sbjct: 264 PGTEYTIYVIALKNNQKSEP 283
Score = 30.0 bits (66), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 20/67 (29%), Positives = 29/67 (43%), Gaps = 15/67 (22%)
Query: 58 THYIVSYRDRTEDWQSVHVDA---------------EYREFTLTQLKCGTHYKINIKLVN 102
T +S+R +TE VDA + R +T+T L+ GT YKI + +N
Sbjct: 127 TTITISWRTKTETITGFQVDAVPANGQTPIQRTIKPDVRSYTITGLQPGTDYKIYLYTLN 186
Query: 103 SIGESKP 109
S P
Sbjct: 187 DNARSSP 193
>pdb|1FNH|A Chain A, Crystal Structure Of Heparin And Integrin Binding Segment
Of Human Fibronectin
Length = 271
Score = 30.4 bits (67), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 38/80 (47%), Gaps = 5/80 (6%)
Query: 32 NILLQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTEDWQSV--HVDAEYREFTLTQLK 89
N+ +TT +S+ + W+P A IT YI+ Y + V E T+T L+
Sbjct: 188 NLRFLATTPNSLLVSWQPPR---ARITGYIIKYEKPGSPPREVVPRPRPGVTEATITGLE 244
Query: 90 CGTHYKINIKLVNSIGESKP 109
GT Y I + + + +S+P
Sbjct: 245 PGTEYTIYVIALKNNQKSEP 264
Score = 30.0 bits (66), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 20/67 (29%), Positives = 29/67 (43%), Gaps = 15/67 (22%)
Query: 58 THYIVSYRDRTEDWQSVHVDA---------------EYREFTLTQLKCGTHYKINIKLVN 102
T +S+R +TE VDA + R +T+T L+ GT YKI + +N
Sbjct: 108 TTITISWRTKTETITGFQVDAVPANGQTPIQRTIKPDVRSYTITGLQPGTDYKIYLYTLN 167
Query: 103 SIGESKP 109
S P
Sbjct: 168 DNARSSP 174
>pdb|3TES|A Chain A, Crystal Structure Of Tencon
pdb|3TES|B Chain B, Crystal Structure Of Tencon
pdb|3TES|C Chain C, Crystal Structure Of Tencon
pdb|3TES|D Chain D, Crystal Structure Of Tencon
Length = 98
Score = 30.4 bits (67), Expect = 0.63, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 38/84 (45%), Gaps = 5/84 (5%)
Query: 28 PGVPNILLQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTEDWQSVH--VDAEYREFTL 85
P N+++ T S+ + W A +++ Y++ + ++++ V R + L
Sbjct: 3 PAPKNLVVSEVTEDSLRLSWTAP---DAAFDSFMIQYQESEKVGEAINLTVPGSERSYDL 59
Query: 86 TQLKCGTHYKINIKLVNSIGESKP 109
T LK GT Y ++I V S P
Sbjct: 60 TGLKPGTEYTVSIYGVKGGHRSNP 83
>pdb|2GEE|A Chain A, Crystal Structure Of Human Type Iii Fibronectin
Extradomain B And Domain 8
Length = 203
Score = 30.0 bits (66), Expect = 0.87, Method: Compositional matrix adjust.
Identities = 30/117 (25%), Positives = 50/117 (42%), Gaps = 35/117 (29%)
Query: 76 VDAEYREFTLTQLKCGTHYKINIKLVNSIGESKPSKTIAASTKGEDQTD--WINI----- 128
VD+ +T+T L+ G Y I++ V + GES P+ T+ T TD + NI
Sbjct: 72 VDSSVGYYTVTGLEPGIDYDISVYTVKNGGESTPT-TLTQQTAVPPPTDLRFTNIGPDTM 130
Query: 129 --------------------PLSNLDEALEMPL-------VIENLLPATRYELTISA 158
P+ N ++ E+ + V+ NLLP T Y +++S+
Sbjct: 131 RVTWAPPPSIDLTNFLVRYSPVKNEEDVAELSISPSDNAVVLTNLLPGTEYVVSVSS 187
>pdb|1X5F|A Chain A, The Solution Structure Of The First Fibronectin Type Iii
Domain Of Human Neogenin
Length = 120
Score = 30.0 bits (66), Expect = 0.93, Method: Compositional matrix adjust.
Identities = 14/35 (40%), Positives = 20/35 (57%)
Query: 130 LSNLDEALEMPLVIENLLPATRYELTISAKNDAGS 164
+ N EM + I+NL+PAT Y + A+N GS
Sbjct: 66 VENTSHPGEMQVTIQNLMPATVYIFRVMAQNKHGS 100
>pdb|3NCC|B Chain B, A Human Prolactin Receptor Antagonist In Complex With
The Mutant Extracellular Domain H188a Of The Human
Prolactin Receptor
pdb|3NCE|B Chain B, A Mutant Human Prolactin Receptor Antagonist H27a In
Complex With The Mutant Extracellular Domain H188a Of
The Human Prolactin Receptor
pdb|3NCF|B Chain B, A Mutant Human Prolactin Receptor Antagonist H30a In
Complex With The Mutant Extracellular Domain H188a Of
The Human Prolactin Receptor
Length = 210
Score = 30.0 bits (66), Expect = 0.94, Method: Compositional matrix adjust.
Identities = 15/46 (32%), Positives = 24/46 (52%), Gaps = 2/46 (4%)
Query: 25 LSPPGVPNIL-LQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTE 69
+ PPG P I +S + + W+P DGG + T+Y ++Y E
Sbjct: 1 MLPPGKPEIFKCRSPNKETFTCWWRPGTDGG-LPTNYSLTYHREGE 45
>pdb|3MZG|B Chain B, Crystal Structure Of A Human Prolactin Receptor
Antagonist In Complex With The Extracellular Domain Of
The Human Prolactin Receptor
pdb|3N06|B Chain B, A Mutant Human Prolactin Receptor Antagonist H27a In
Complex With The Extracellular Domain Of The Human
Prolactin Receptor
pdb|3N0P|B Chain B, A Mutant Human Prolactin Receptor Antagonist H30a In
Complex With The Extracellular Domain Of The Human
Prolactin Receptor
pdb|3NCB|B Chain B, A Mutant Human Prolactin Receptor Antagonist H180a In
Complex With The Extracellular Domain Of The Human
Prolactin Receptor
Length = 210
Score = 29.6 bits (65), Expect = 0.98, Method: Compositional matrix adjust.
Identities = 15/46 (32%), Positives = 24/46 (52%), Gaps = 2/46 (4%)
Query: 25 LSPPGVPNIL-LQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTE 69
+ PPG P I +S + + W+P DGG + T+Y ++Y E
Sbjct: 1 MLPPGKPEIFKCRSPNKETFTCWWRPGTDGG-LPTNYSLTYHREGE 45
>pdb|3D48|R Chain R, Crystal Structure Of A Prolactin Receptor Antagonist
Bound To The Extracellular Domain Of The Prolactin
Receptor
Length = 211
Score = 29.6 bits (65), Expect = 0.98, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 23/44 (52%), Gaps = 2/44 (4%)
Query: 27 PPGVPNIL-LQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTE 69
PPG P I +S + + W+P DGG + T+Y ++Y E
Sbjct: 4 PPGKPEIFKCRSPNKETFTCWWRPGTDGG-LPTNYSLTYHREGE 46
>pdb|1BP3|B Chain B, The Xray Structure Of A Growth Hormone-Prolactin
Receptor Complex
Length = 211
Score = 29.6 bits (65), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 23/44 (52%), Gaps = 2/44 (4%)
Query: 27 PPGVPNIL-LQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTE 69
PPG P I +S + + W+P DGG + T+Y ++Y E
Sbjct: 3 PPGKPEIFKCRSPNKETFTCWWRPGTDGG-LPTNYSLTYHREGE 45
>pdb|1X5X|A Chain A, Solution Structure Of The Fibronectin Type-Iii Domain Of
Human Fibronectin Type Iii Domain Containing Protein 3
Length = 109
Score = 29.6 bits (65), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 2/77 (2%)
Query: 43 ISILW-KPSYDGGAIITHYIVSYRDRTEDWQ-SVHVDAEYREFTLTQLKCGTHYKINIKL 100
+S+ W KPS YI+ + T + D E +T+ L+ T YK +
Sbjct: 24 LSLQWSKPSGTPSDEGISYILEMEEETSGYGFKPKYDGEDLAYTVKNLRRSTKYKFKVIA 83
Query: 101 VNSIGESKPSKTIAAST 117
NS G+S PS+ + +T
Sbjct: 84 YNSEGKSNPSEVVEFTT 100
>pdb|2YD4|A Chain A, Crystal Structure Of The N-Terminal Ig1-2 Module Of
Chicken Receptor Protein Tyrosine Phosphatase Sigma
Length = 210
Score = 29.6 bits (65), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 13/33 (39%), Positives = 20/33 (60%), Gaps = 4/33 (12%)
Query: 5 YTCLADNIFGKDDIYYQVTILS----PPGVPNI 33
Y C+A N G+ ++ ++T+L PPG PNI
Sbjct: 79 YECVAQNPHGEVTVHAKLTVLREDQLPPGFPNI 111
>pdb|1TDQ|A Chain A, Structural Basis For The Interactions Between Tenascins
And The C-Type Lectin Domains From Lecticans: Evidence
For A Cross-Linking Role For Tenascins
Length = 283
Score = 29.3 bits (64), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 17/67 (25%), Positives = 34/67 (50%), Gaps = 3/67 (4%)
Query: 32 NILLQSTTTHSISILWKPSYDGGAIITHYIVSYRDRTEDWQSVHVDAEYREFTLTQLKCG 91
++++ +++ SIS++W I HY +++ + V V + +TLT L+ G
Sbjct: 202 DLMVTASSETSISLIWT---KASGPIDHYRITFTPSSGISSEVTVPRDRTSYTLTDLEPG 258
Query: 92 THYKINI 98
Y I+I
Sbjct: 259 AEYIISI 265
>pdb|2E7H|A Chain A, Solution Structure Of The Second Fn3 Domain From Human
Ephrin Type-B Receptor 4
Length = 109
Score = 28.9 bits (63), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 19/81 (23%), Positives = 35/81 (43%), Gaps = 2/81 (2%)
Query: 27 PPGVPNILLQSTTTHSISILWK-PSYDGGAIITHYIVSYRDRTEDWQSVH-VDAEYREFT 84
PP V +I + ++ S+S+ W P GA++ + + + E SV +
Sbjct: 8 PPAVSDIRVTRSSPSSLSLAWAVPRAPSGAVLDYEVKYHEKGAEGPSSVRFLKTSENRAE 67
Query: 85 LTQLKCGTHYKINIKLVNSIG 105
L LK G Y + ++ + G
Sbjct: 68 LRGLKRGASYLVQVRARSEAG 88
>pdb|4GO6|B Chain B, Crystal Structure Of Hcf-1 Self-Association Sequence 1
pdb|4GO6|D Chain D, Crystal Structure Of Hcf-1 Self-Association Sequence 1
Length = 232
Score = 28.5 bits (62), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 12/50 (24%), Positives = 22/50 (44%)
Query: 57 ITHYIVSYRDRTEDWQSVHVDAEYREFTLTQLKCGTHYKINIKLVNSIGE 106
+THY + D + +Y + +L+ GT YK + +N+ G
Sbjct: 22 VTHYFLPPDDAVPSDDDLGTVPDYNQLKKQELQPGTAYKFRVAGINACGR 71
>pdb|1X4Y|A Chain A, Solution Structure Of The 3rd Fibronectin Type Iii Domain
From Mouse Biregional Cell Adhesion
Molecule-RelatedDOWN- Regulated Oncogenes (Cdon) Binding
Protein
Length = 114
Score = 28.5 bits (62), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 39/84 (46%), Gaps = 4/84 (4%)
Query: 39 TTHSISILWKPSYDGGAIITHYIVSYR----DRTEDWQSVHVDAEYREFTLTQLKCGTHY 94
TT + ++ P+ + I + + YR D D++ V+ + +++ L+ T Y
Sbjct: 23 TTIMLKWMYIPASNNNTPIHGFYIYYRPTDSDNDSDYKKDMVEGDRYWHSISHLQPETSY 82
Query: 95 KINIKLVNSIGESKPSKTIAASTK 118
I ++ N GES+ S + TK
Sbjct: 83 DIKMQCFNEGGESEFSNVMICETK 106
>pdb|3N1G|C Chain C, Crystal Structure Of Dhhn Bound To Bocfn3
pdb|3N1G|D Chain D, Crystal Structure Of Dhhn Bound To Bocfn3
pdb|3N1M|C Chain C, Crystal Structure Of Ihhn Bound To Bocfn3
pdb|3N1P|C Chain C, Crystal Structure Of Ihhn Bound To Bocfn3
Length = 111
Score = 28.5 bits (62), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 20/86 (23%), Positives = 39/86 (45%), Gaps = 4/86 (4%)
Query: 39 TTHSISILWKPSYDGGAIITHYIVSYR----DRTEDWQSVHVDAEYREFTLTQLKCGTHY 94
TT + ++ P+ + I + + YR D D++ V+ + +++ L+ T Y
Sbjct: 21 TTIMLKWMYIPASNNNTPIHGFYIYYRPTDSDNDSDYKKDMVEGDKYWHSISHLQPETSY 80
Query: 95 KINIKLVNSIGESKPSKTIAASTKGE 120
I ++ N GES+ S + TK
Sbjct: 81 DIKMQCFNEGGESEFSNVMICETKAR 106
>pdb|2HM1|A Chain A, Crystal Structure Of Human Beta-Secretase (Bace) In The
Presence Of An Inhibitor (2)
pdb|2IQG|A Chain A, Crystal Structure Of Hydroxyethyl Secondary Amine-Based
Peptidomimetic Inhibitor Of Human Beta-Secretase (Bace)
pdb|3IVH|A Chain A, Design And Synthesis Of Potent Bace-1 Inhibitors With
Cellular Activity: Structure-Activity Relationship Of
P1 Substituents
pdb|3IVI|A Chain A, Design And Synthesis Of Potent Bace-1 Inhibitors With
Cellular Activity: Structure-Activity Relationship Of
P1 Substituents
pdb|3IVI|B Chain B, Design And Synthesis Of Potent Bace-1 Inhibitors With
Cellular Activity: Structure-Activity Relationship Of
P1 Substituents
pdb|3IVI|C Chain C, Design And Synthesis Of Potent Bace-1 Inhibitors With
Cellular Activity: Structure-Activity Relationship Of
P1 Substituents
pdb|3NSH|A Chain A, Bace-1 In Complex With Eln475957
pdb|3NSH|B Chain B, Bace-1 In Complex With Eln475957
pdb|3NSH|C Chain C, Bace-1 In Complex With Eln475957
pdb|3N4L|A Chain A, Bace-1 In Complex With Eln380842
pdb|3N4L|B Chain B, Bace-1 In Complex With Eln380842
pdb|3N4L|C Chain C, Bace-1 In Complex With Eln380842
Length = 406
Score = 28.1 bits (61), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 14/43 (32%), Positives = 26/43 (60%), Gaps = 2/43 (4%)
Query: 1 MVGNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
M G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 1 MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 43
>pdb|4DPF|A Chain A, Bace-1 In Complex With A Hea-Macrocyclic Type Inhibitor
pdb|4DPI|A Chain A, Bace-1 In Complex With Hea-Macrocyclic Inhibitor,
Mv078512
Length = 391
Score = 28.1 bits (61), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 14/43 (32%), Positives = 26/43 (60%), Gaps = 2/43 (4%)
Query: 1 MVGNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
M G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 1 MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 43
>pdb|3P4L|A Chain A, Crystal Structure Of A Hemojuvelin-Binding Fragment Of
Neogenin
Length = 211
Score = 28.1 bits (61), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 23/102 (22%), Positives = 39/102 (38%), Gaps = 4/102 (3%)
Query: 20 YQVTILSPPGVPNILLQSTTTHSISILWKPSYDGGAIITHYIVSYRD----RTEDWQSVH 75
+++ SPP ++ + +I + W+P + IT YI+ Y DW
Sbjct: 101 FELVPTSPPKDVTVVSKEGKPKTIIVNWQPPSEANGKITGYIIYYSTDVNAEIHDWVIEP 160
Query: 76 VDAEYREFTLTQLKCGTHYKINIKLVNSIGESKPSKTIAAST 117
V + +L T Y I+ NS G S+ + T
Sbjct: 161 VVGNRLTHQIQELTLDTPYYFKIQARNSKGMGPMSEAVQFRT 202
>pdb|1X5K|A Chain A, The Solution Structure Of The Sixth Fibronectin Type Iii
Domain Of Human Neogenin
Length = 124
Score = 27.3 bits (59), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 21/90 (23%), Positives = 35/90 (38%), Gaps = 4/90 (4%)
Query: 20 YQVTILSPPGVPNILLQSTTTHSISILWKPSYDGGAIITHYIVSYRD----RTEDWQSVH 75
+++ SPP ++ + +I + W+P + IT YI+ Y DW
Sbjct: 14 FELVPTSPPKDVTVVSKEGKPKTIIVNWQPPSEANGKITGYIIYYSTDVNAEIHDWVIEP 73
Query: 76 VDAEYREFTLTQLKCGTHYKINIKLVNSIG 105
V + +L T Y I+ NS G
Sbjct: 74 VVGNRLTHQIQELTLDTPYYFKIQARNSKG 103
>pdb|1F97|A Chain A, Soluble Part Of The Junction Adhesion Molecule From Mouse
Length = 212
Score = 27.3 bits (59), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 13/40 (32%), Positives = 22/40 (55%), Gaps = 2/40 (5%)
Query: 3 GNYTCLADNIFGKD--DIYYQVTILSPPGVPNILLQSTTT 40
G YTC+ G++ ++ +T+L PP P I + S+ T
Sbjct: 78 GEYTCMVSEEGGQNYGEVSIHLTVLVPPSKPTISVPSSVT 117
>pdb|2OF0|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 5
pdb|2OHK|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
1- Amino-Isoquinoline
pdb|2OHL|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
2- Aminoquinoline
pdb|2OHM|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
N~3~-Benzylpyridine-2,3-Diamine
pdb|2OHN|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
4- (4-Fluorobenzyl)piperidine
pdb|2OHQ|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 4
pdb|2OHR|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 6a
pdb|2OHS|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 6b
pdb|2OHT|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 7
pdb|2OHU|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 8b
pdb|2OHP|A Chain A, X-ray Crystal Structure Of Beta Secretase Complexed With
Compound 3
Length = 402
Score = 26.9 bits (58), Expect = 7.9, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 14 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 54
>pdb|3LPI|A Chain A, Structure Of Bace Bound To Sch745132
pdb|3LPI|B Chain B, Structure Of Bace Bound To Sch745132
pdb|3LPJ|A Chain A, Structure Of Bace Bound To Sch743641
pdb|3LPJ|B Chain B, Structure Of Bace Bound To Sch743641
pdb|3LPK|A Chain A, Structure Of Bace Bound To Sch747123
pdb|3LPK|B Chain B, Structure Of Bace Bound To Sch747123
pdb|3OHF|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-655295 Aka N~3~-((1s,2r)-1-
Benzyl-2-Hydroxy-3-((3-
Methoxybenzyl)amino)propyl)-N~1~,
N~1~-Dibutyl-1h-Indole-1,3- Dicarboxamide
pdb|3OHF|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-655295 Aka N~3~-((1s,2r)-1-
Benzyl-2-Hydroxy-3-((3-
Methoxybenzyl)amino)propyl)-N~1~,
N~1~-Dibutyl-1h-Indole-1,3- Dicarboxamide
pdb|3OHH|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-681889 Aka
N~1~-Butyl-5-Cyano- N~3~-((1s,2r)-1-(3,5-
Difluorobenzyl)-2-Hydroxy-3-((3-
Methoxybenzyl)amino)propyl)-N~1~- Methyl-1h-Indole-1,3-
Dicarboxamide
pdb|3OHH|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-681889 Aka
N~1~-Butyl-5-Cyano- N~3~-((1s,2r)-1-(3,5-
Difluorobenzyl)-2-Hydroxy-3-((3-
Methoxybenzyl)amino)propyl)-N~1~- Methyl-1h-Indole-1,3-
Dicarboxamide
pdb|3R2F|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-693391 Aka
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-((1s,2r)-1-(3,
5-Difluorobenzyl)-2-Hydroxy-2-((2r,4r)-
4-Propoxy-2-Pyrrolidinyl)ethyl)-4-Phenylbutanamide
pdb|3R2F|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-693391 Aka
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-((1s,2r)-1-(3,
5-Difluorobenzyl)-2-Hydroxy-2-((2r,4r)-
4-Propoxy-2-Pyrrolidinyl)ethyl)-4-Phenylbutanamide
pdb|3R2F|D Chain D, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-693391 Aka
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-((1s,2r)-1-(3,
5-Difluorobenzyl)-2-Hydroxy-2-((2r,4r)-
4-Propoxy-2-Pyrrolidinyl)ethyl)-4-Phenylbutanamide
pdb|3R2F|E Chain E, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-693391 Aka
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-((1s,2r)-1-(3,
5-Difluorobenzyl)-2-Hydroxy-2-((2r,4r)-
4-Propoxy-2-Pyrrolidinyl)ethyl)-4-Phenylbutanamide
pdb|3SKF|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With
(2s)-2-((3s)-3-(Acetylamino)-3-(Butan-2-Yl)-2-
Oxopyrrolidin-1-
Yl)-N-((2s,
3r)-3-Hydroxy-4-((3-Methoxybenzyl)amino)-1-Phenylbutan-
2- Yl)-4-Phenylbutanamide
pdb|3SKF|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With
(2s)-2-((3s)-3-(Acetylamino)-3-(Butan-2-Yl)-2-
Oxopyrrolidin-1-
Yl)-N-((2s,
3r)-3-Hydroxy-4-((3-Methoxybenzyl)amino)-1-Phenylbutan-
2- Yl)-4-Phenylbutanamide
pdb|3SKG|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-
((1s,2r)-1-(3,5-Difluorobenzyl)-2-Hydroxy-2-(1,2,3,
4-Tetrahydro-3- Isoquinolinyl)ethyl)-4-Phenylbutanamide
pdb|3SKG|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-
((1s,2r)-1-(3,5-Difluorobenzyl)-2-Hydroxy-2-(1,2,3,
4-Tetrahydro-3- Isoquinolinyl)ethyl)-4-Phenylbutanamide
pdb|3SKG|D Chain D, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-
((1s,2r)-1-(3,5-Difluorobenzyl)-2-Hydroxy-2-(1,2,3,
4-Tetrahydro-3- Isoquinolinyl)ethyl)-4-Phenylbutanamide
pdb|3SKG|E Chain E, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-
((1s,2r)-1-(3,5-Difluorobenzyl)-2-Hydroxy-2-(1,2,3,
4-Tetrahydro-3- Isoquinolinyl)ethyl)-4-Phenylbutanamide
pdb|4FSE|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With N-(N-(4-Amino-3,5-
Dichlorobenzyl)carbamimidoyl)-3-(4- Methoxyphenyl)-5-
Methyl-4-Isothiazolecarboxamide
pdb|4FSE|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With N-(N-(4-Amino-3,5-
Dichlorobenzyl)carbamimidoyl)-3-(4- Methoxyphenyl)-5-
Methyl-4-Isothiazolecarboxamide
pdb|4FSE|D Chain D, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With N-(N-(4-Amino-3,5-
Dichlorobenzyl)carbamimidoyl)-3-(4- Methoxyphenyl)-5-
Methyl-4-Isothiazolecarboxamide
pdb|4FSE|E Chain E, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With N-(N-(4-Amino-3,5-
Dichlorobenzyl)carbamimidoyl)-3-(4- Methoxyphenyl)-5-
Methyl-4-Isothiazolecarboxamide
Length = 455
Score = 26.9 bits (58), Expect = 8.1, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 59 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 99
>pdb|2VA5|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 8c
pdb|2VA6|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 24
pdb|2VA7|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 27
Length = 455
Score = 26.9 bits (58), Expect = 8.1, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 60 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 100
>pdb|2HIZ|A Chain A, Crystal Structure Of Human Beta-Secretase (Bace) In The
Presence Of An Inhibitor
pdb|2HIZ|B Chain B, Crystal Structure Of Human Beta-Secretase (Bace) In The
Presence Of An Inhibitor
pdb|2HIZ|C Chain C, Crystal Structure Of Human Beta-Secretase (Bace) In The
Presence Of An Inhibitor
pdb|2P83|A Chain A, Potent And Selective Isophthalamide S2 Hydroxyethylamine
Inhibitor Of Bace1
pdb|2P83|B Chain B, Potent And Selective Isophthalamide S2 Hydroxyethylamine
Inhibitor Of Bace1
pdb|2P83|C Chain C, Potent And Selective Isophthalamide S2 Hydroxyethylamine
Inhibitor Of Bace1
Length = 455
Score = 26.9 bits (58), Expect = 8.1, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 60 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 100
>pdb|3JXA|A Chain A, Immunoglobulin Domains 1-4 Of Mouse Cntn4
pdb|3JXA|B Chain B, Immunoglobulin Domains 1-4 Of Mouse Cntn4
Length = 383
Score = 26.9 bits (58), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 14/51 (27%), Positives = 24/51 (47%)
Query: 3 GNYTCLADNIFGKDDIYYQVTILSPPGVPNILLQSTTTHSISILWKPSYDG 53
G+Y C+A+N GK+ Q+T + P I+ S+ W+ +G
Sbjct: 270 GSYECVAENSRGKNVAKGQLTFYAQPNWVQIINDIHVAMEESVFWECKANG 320
>pdb|2ZJN|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
N-[1-(5-Chloro-2-Isopropoxy-3-Methoxy-Benzyl)-
Piperidin-4-Yl]-2-(2-Methyl-4-Sulfamoyl-Phenoxy)-
Acetamide
pdb|3H0B|A Chain A, Discovery Of Aminoheterocycles As A Novel Beta-Secretase
Inhibitor Class
pdb|3H0B|B Chain B, Discovery Of Aminoheterocycles As A Novel Beta-Secretase
Inhibitor Class
pdb|3H0B|C Chain C, Discovery Of Aminoheterocycles As A Novel Beta-Secretase
Inhibitor Class
Length = 405
Score = 26.9 bits (58), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 17 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 57
>pdb|3DM6|A Chain A, Beta-Secretase 1 Complexed With Statine-Based Inhibitor
pdb|3DM6|B Chain B, Beta-Secretase 1 Complexed With Statine-Based Inhibitor
pdb|3DM6|C Chain C, Beta-Secretase 1 Complexed With Statine-Based Inhibitor
pdb|3I25|A Chain A, Potent Beta-Secretase 1 Hydroxyethylene Inhibitor
pdb|3I25|B Chain B, Potent Beta-Secretase 1 Hydroxyethylene Inhibitor
pdb|3I25|C Chain C, Potent Beta-Secretase 1 Hydroxyethylene Inhibitor
Length = 406
Score = 26.9 bits (58), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 18 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 58
>pdb|2QU2|A Chain A, Bace1 With Compound 1
pdb|2QU3|A Chain A, Bace1 With Compound 2
pdb|2ZDZ|A Chain A, X-Ray Structure Of Bace-1 In Complex With Compound
3.B.10
pdb|2ZE1|A Chain A, X-Ray Structure Of Bace-1 In Complex With Compound 6g
pdb|3IGB|A Chain A, Bace-1 With Compound 3
pdb|3IN3|A Chain A, Bace1 With Compound 30
pdb|3IN4|A Chain A, Bace1 With Compound 38
pdb|3IND|A Chain A, Bace1 With The Aminohydantoin Compound 29
pdb|3INE|A Chain A, Bace1 With The Aminohydantoin Compound S-34
pdb|3INF|A Chain A, Bace1 With The Aminohydantoin Compound 37
pdb|3INH|A Chain A, Bace1 With The Aminohydantoin Compound R-58
pdb|3LHG|A Chain A, Bace1 In Complex With The Aminohydantoin Compound 4g
pdb|3L38|A Chain A, Bace1 In Complex With The Aminopyridine Compound 44
pdb|3L3A|A Chain A, Bace-1 With The Aminopyridine Compound 32
pdb|3OOZ|A Chain A, Bace1 In Complex With The Aminohydantoin Compound 102
pdb|3S7L|A Chain A, Pyrazolyl And Thienyl Aminohydantoins As Potent Bace1
Inhibitors
pdb|3S7M|A Chain A, Pyrazolyl And Thienyl Aminohydantoins As Potent Bace1
Inhibitors
Length = 415
Score = 26.9 bits (58), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 13 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 53
>pdb|3IXK|A Chain A, Potent Beta-Secretase 1 Inhibitor
pdb|3IXK|B Chain B, Potent Beta-Secretase 1 Inhibitor
pdb|3IXK|C Chain C, Potent Beta-Secretase 1 Inhibitor
pdb|3KYR|A Chain A, Bace-1 In Complex With A Norstatine Type Inhibitor
pdb|3KYR|B Chain B, Bace-1 In Complex With A Norstatine Type Inhibitor
pdb|3KYR|C Chain C, Bace-1 In Complex With A Norstatine Type Inhibitor
Length = 405
Score = 26.9 bits (58), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 17 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 57
>pdb|2QZL|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Ixs
Length = 411
Score = 26.9 bits (58), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 23 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 63
>pdb|2QK5|A Chain A, Structure Of Bace1 Bound To Sch626485
pdb|2QK5|B Chain B, Structure Of Bace1 Bound To Sch626485
pdb|2QMD|A Chain A, Structure Of Bace Bound To Sch722924
pdb|2QMD|B Chain B, Structure Of Bace Bound To Sch722924
pdb|2QMF|A Chain A, Structure Of Bace Bound To Sch735310
pdb|2QMF|B Chain B, Structure Of Bace Bound To Sch735310
pdb|2QP8|A Chain A, Structure Of Bace Bound To Sch734723
pdb|2QP8|B Chain B, Structure Of Bace Bound To Sch734723
pdb|2QMG|A Chain A, Structure Of Bace Bound To Sch745966
pdb|2QMG|B Chain B, Structure Of Bace Bound To Sch745966
Length = 395
Score = 26.9 bits (58), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 6 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 46
>pdb|3L58|A Chain A, Structure Of Bace Bound To Sch589432
pdb|3L58|B Chain B, Structure Of Bace Bound To Sch589432
pdb|3L59|A Chain A, Structure Of Bace Bound To Sch710413
pdb|3L59|B Chain B, Structure Of Bace Bound To Sch710413
pdb|3L5B|A Chain A, Structure Of Bace Bound To Sch713601
pdb|3L5B|B Chain B, Structure Of Bace Bound To Sch713601
pdb|3L5C|A Chain A, Structure Of Bace Bound To Sch723871
pdb|3L5C|B Chain B, Structure Of Bace Bound To Sch723871
pdb|3L5D|A Chain A, Structure Of Bace Bound To Sch723873
pdb|3L5D|B Chain B, Structure Of Bace Bound To Sch723873
pdb|3L5E|A Chain A, Structure Of Bace Bound To Sch736062
pdb|3L5E|B Chain B, Structure Of Bace Bound To Sch736062
pdb|3L5F|A Chain A, Structure Of Bace Bound To Sch736201
pdb|3L5F|B Chain B, Structure Of Bace Bound To Sch736201
pdb|4DJU|A Chain A, Structure Of Bace Bound To
2-Imino-3-Methyl-5,5-Diphenylimidazolidin- 4-One
pdb|4DJU|B Chain B, Structure Of Bace Bound To
2-Imino-3-Methyl-5,5-Diphenylimidazolidin- 4-One
pdb|4DJV|A Chain A, Structure Of Bace Bound To
2-Imino-5-(3'-Methoxy-[1,1'-Biphenyl]-3-
Yl)-3-Methyl-5-Phenylimidazolidin-4-One
pdb|4DJV|B Chain B, Structure Of Bace Bound To
2-Imino-5-(3'-Methoxy-[1,1'-Biphenyl]-3-
Yl)-3-Methyl-5-Phenylimidazolidin-4-One
pdb|4DJW|A Chain A, Structure Of Bace Bound To
2-Imino-3-Methyl-5-Phenyl-5-(3-(Pyridin-3-
Yl)phenyl)imidazolidin-4-One
pdb|4DJW|B Chain B, Structure Of Bace Bound To
2-Imino-3-Methyl-5-Phenyl-5-(3-(Pyridin-3-
Yl)phenyl)imidazolidin-4-One
pdb|4DJX|A Chain A, Structure Of Bace Bound To
5-(3-(5-Chloropyridin-3-Yl)phenyl)-5-
Cyclopropyl-2-Imino-3-Methylimidazolidin-4-One
pdb|4DJX|B Chain B, Structure Of Bace Bound To
5-(3-(5-Chloropyridin-3-Yl)phenyl)-5-
Cyclopropyl-2-Imino-3-Methylimidazolidin-4-One
pdb|4DJY|A Chain A, Structure Of Bace Bound To
(R)-5-Cyclopropyl-2-Imino-3-Methyl-5-(3-(5-
(Prop-1-Yn-1-Yl)pyridin-3-Yl)phenyl)imidazolidin-4-One
pdb|4DJY|B Chain B, Structure Of Bace Bound To
(R)-5-Cyclopropyl-2-Imino-3-Methyl-5-(3-(5-
(Prop-1-Yn-1-Yl)pyridin-3-Yl)phenyl)imidazolidin-4-One
pdb|4H1E|A Chain A, Structure Of Bace-1 Bound To
(7ar)-6-Benzoyl-7a-(4-(3-Cyanophenyl)
Thiophen-2-Yl)-3-Methyl-4-Oxohexahydro-1h-Pyrrolo[3,
4-D]pyrimidin- 2(3h)-Iminium
pdb|4H1E|B Chain B, Structure Of Bace-1 Bound To
(7ar)-6-Benzoyl-7a-(4-(3-Cyanophenyl)
Thiophen-2-Yl)-3-Methyl-4-Oxohexahydro-1h-Pyrrolo[3,
4-D]pyrimidin- 2(3h)-Iminium
pdb|4H3J|A Chain A, Structure Of Bace Bound To
2-Fluoro-5-(5-(2-Imino-3-Methyl-4-Oxo-6-
Phenyloctahydro-1h-Pyrrolo[3,
4-D]pyrimidin-7a-Yl)thiophen-2-Yl) Benzonitrile
pdb|4H3J|B Chain B, Structure Of Bace Bound To
2-Fluoro-5-(5-(2-Imino-3-Methyl-4-Oxo-6-
Phenyloctahydro-1h-Pyrrolo[3,
4-D]pyrimidin-7a-Yl)thiophen-2-Yl) Benzonitrile
pdb|4HA5|A Chain A, Structure Of Bace Bound To
(S)-3-(5-(2-Imino-1,4-Dimethyl-6-
Oxohexahydropyrimidin-4-Yl)thiophen-3-Yl)benzonitrile
pdb|4HA5|B Chain B, Structure Of Bace Bound To
(S)-3-(5-(2-Imino-1,4-Dimethyl-6-
Oxohexahydropyrimidin-4-Yl)thiophen-3-Yl)benzonitrile
pdb|4H3F|A Chain A, Structure Of Bace Bound To
3-(5-((7ar)-2-Imino-6-(6-Methoxypyridin-2-
Yl)-3-Methyl-4-Oxooctahydro-1h-Pyrrolo[3,
4-D]pyrimidin-7a-Yl) Thiophen-3-Yl)benzonitrile
pdb|4H3F|B Chain B, Structure Of Bace Bound To
3-(5-((7ar)-2-Imino-6-(6-Methoxypyridin-2-
Yl)-3-Methyl-4-Oxooctahydro-1h-Pyrrolo[3,
4-D]pyrimidin-7a-Yl) Thiophen-3-Yl)benzonitrile
pdb|4H3G|A Chain A, Structure Of Bace Bound To
2-((7ar)-7a-(4-(3-Cyanophenyl)thiophen-2-
Yl)-2-Imino-3-Methyl-4-Oxohexahydro-1h-Pyrrolo[3,
4-D]pyrimidin-6(2h)- Yl)nicotinonitrile
pdb|4H3G|B Chain B, Structure Of Bace Bound To
2-((7ar)-7a-(4-(3-Cyanophenyl)thiophen-2-
Yl)-2-Imino-3-Methyl-4-Oxohexahydro-1h-Pyrrolo[3,
4-D]pyrimidin-6(2h)- Yl)nicotinonitrile
pdb|4H3I|A Chain A, Structure Of Bace Bound To
3-(5-((7ar)-2-Imino-6-(3-Methoxypyridin-2-
Yl)-3-Methyl-4-Oxooctahydro-1h-Pyrrolo[3,
4-D]pyrimidin-7a-Yl) Thiophen-3-Yl)benzonitrile
pdb|4H3I|B Chain B, Structure Of Bace Bound To
3-(5-((7ar)-2-Imino-6-(3-Methoxypyridin-2-
Yl)-3-Methyl-4-Oxooctahydro-1h-Pyrrolo[3,
4-D]pyrimidin-7a-Yl) Thiophen-3-Yl)benzonitrile
Length = 414
Score = 26.6 bits (57), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 18 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 58
>pdb|3KLD|A Chain A, Ptprg Cntn4 Complex
Length = 384
Score = 26.6 bits (57), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 14/51 (27%), Positives = 24/51 (47%)
Query: 3 GNYTCLADNIFGKDDIYYQVTILSPPGVPNILLQSTTTHSISILWKPSYDG 53
G+Y C+A+N GK+ Q+T + P I+ S+ W+ +G
Sbjct: 271 GSYECVAENSRGKNVAKGQLTFYAQPNWVQIINDIHVAMEESVFWECKANG 321
>pdb|2ZHR|A Chain A, Crystal Structure Of Bace1 In Complex With Om99-2 At Ph
5.0
pdb|2ZHR|B Chain B, Crystal Structure Of Bace1 In Complex With Om99-2 At Ph
5.0
pdb|2ZHS|A Chain A, Crystal Structure Of Bace1 At Ph 4.0
pdb|2ZHT|A Chain A, Crystal Structure Of Bace1 At Ph 4.5
pdb|2ZHU|A Chain A, Crystal Structure Of Bace1 At Ph 5.0
pdb|2ZHV|A Chain A, Crystal Structure Of Bace1 At Ph 7.0
Length = 411
Score = 26.6 bits (57), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 15 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 55
>pdb|3BRA|A Chain A, Bace-1 Complexed With Compound 1
pdb|3BUF|A Chain A, Bace-1 Complexed With Compound 2
pdb|3BUG|A Chain A, Bace-1 Complexed With Compound 3
pdb|3BUH|A Chain A, Bace-1 Complexed With Compound 4
Length = 409
Score = 26.6 bits (57), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 13 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 53
>pdb|1FKN|A Chain A, Structure Of Beta-Secretase Complexed With Inhibitor
pdb|1FKN|B Chain B, Structure Of Beta-Secretase Complexed With Inhibitor
pdb|1M4H|A Chain A, Crystal Structure Of Beta-Secretase Complexed With
Inhibitor Om00-3
pdb|1M4H|B Chain B, Crystal Structure Of Beta-Secretase Complexed With
Inhibitor Om00-3
Length = 391
Score = 26.6 bits (57), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 3 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 43
>pdb|3VV6|A Chain A, Crystal Structure Of Beta Secetase In Complex With
2-Amino-3-Methyl-6- ((1s,
2r)-2-Phenylcyclopropyl)pyrimidin-4(3h)-One
pdb|3VV7|A Chain A, Crystal Structure Of Beta Secetase In Complex With
2-Amino-6-((1s,2r)-
2-(3'-Methoxybiphenyl-3-Yl)cyclopropyl)-3-
Methylpyrimidin-4(3h)-One
pdb|3VV8|A Chain A, Crystal Structure Of Beta Secetase In Complex With
2-Amino-3-Methyl-6-
((1s,
2r)-2-(3'-Methylbiphenyl-4-Yl)cyclopropyl)pyrimidin-
4(3h)-One
Length = 416
Score = 26.6 bits (57), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 20 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 60
>pdb|1YM2|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Nvp-Aur200
pdb|1YM2|B Chain B, Crystal Structure Of Human Beta Secretase Complexed With
Nvp-Aur200
pdb|1YM2|C Chain C, Crystal Structure Of Human Beta Secretase Complexed With
Nvp-Aur200
pdb|2F3E|A Chain A, Crystal Structure Of The Bace Complex With Axq093, A
Macrocyclic Inhibitor
pdb|2F3E|B Chain B, Crystal Structure Of The Bace Complex With Axq093, A
Macrocyclic Inhibitor
pdb|2F3E|C Chain C, Crystal Structure Of The Bace Complex With Axq093, A
Macrocyclic Inhibitor
pdb|2F3F|A Chain A, Crystal Structure Of The Bace Complex With Bdf488, A
Macrocyclic Inhibitor
pdb|2F3F|B Chain B, Crystal Structure Of The Bace Complex With Bdf488, A
Macrocyclic Inhibitor
pdb|2F3F|C Chain C, Crystal Structure Of The Bace Complex With Bdf488, A
Macrocyclic Inhibitor
pdb|3DUY|A Chain A, Crystal Structure Of Human Beta-Secretase In Complex
With Nvp-Afj144
pdb|3DUY|B Chain B, Crystal Structure Of Human Beta-Secretase In Complex
With Nvp-Afj144
pdb|3DUY|C Chain C, Crystal Structure Of Human Beta-Secretase In Complex
With Nvp-Afj144
pdb|3DV1|A Chain A, Crystal Structure Of Human Beta-Secretase In Complex
With Nvp-Arv999
pdb|3DV1|B Chain B, Crystal Structure Of Human Beta-Secretase In Complex
With Nvp-Arv999
pdb|3DV1|C Chain C, Crystal Structure Of Human Beta-Secretase In Complex
With Nvp-Arv999
pdb|3DV5|A Chain A, Crystal Structure Of Human Beta-Secretase In Complex
With Nvp-Bav544
pdb|3DV5|B Chain B, Crystal Structure Of Human Beta-Secretase In Complex
With Nvp-Bav544
pdb|3DV5|C Chain C, Crystal Structure Of Human Beta-Secretase In Complex
With Nvp-Bav544
pdb|3K5C|A Chain A, Human Bace-1 Complex With Nb-216
pdb|3K5C|B Chain B, Human Bace-1 Complex With Nb-216
pdb|3K5C|C Chain C, Human Bace-1 Complex With Nb-216
pdb|3K5F|A Chain A, Human Bace-1 Complex With Ayh011
pdb|3K5F|B Chain B, Human Bace-1 Complex With Ayh011
pdb|3K5F|C Chain C, Human Bace-1 Complex With Ayh011
pdb|3K5G|A Chain A, Human Bace-1 Complex With Bjc060
pdb|3K5G|B Chain B, Human Bace-1 Complex With Bjc060
pdb|3K5G|C Chain C, Human Bace-1 Complex With Bjc060
pdb|3PI5|A Chain A, Crystal Structure Of Human Beta Secretase In Complex
With Bfg356
pdb|3PI5|B Chain B, Crystal Structure Of Human Beta Secretase In Complex
With Bfg356
pdb|3PI5|C Chain C, Crystal Structure Of Human Beta Secretase In Complex
With Bfg356
pdb|3QBH|A Chain A, Structure Based Design, Synthesis And Sar Of Cyclic
Hydroxyethylamine (Hea) Bace-1 Inhibitors
pdb|3QBH|B Chain B, Structure Based Design, Synthesis And Sar Of Cyclic
Hydroxyethylamine (Hea) Bace-1 Inhibitors
pdb|3QBH|C Chain C, Structure Based Design, Synthesis And Sar Of Cyclic
Hydroxyethylamine (Hea) Bace-1 Inhibitors
pdb|3VEU|A Chain A, Crystal Structure Of Human Beta Secretase In Complex
With Nvp-Avi326
pdb|3VF3|A Chain A, Crystal Structure Of Human Beta Secretase In Complex
With Nvp-Bqq711
pdb|3VG1|A Chain A, Crystal Structure Of Human Beta Secretase In Complex
With Nvp-Bur436, Derived From A Soaking Experiment
pdb|4D83|A Chain A, Crystal Structure Of Human Beta Secretase In Complex
With Nvp-Bur436, Derived From A Co-Crystallization
Experiment
pdb|4D83|B Chain B, Crystal Structure Of Human Beta Secretase In Complex
With Nvp-Bur436, Derived From A Co-Crystallization
Experiment
pdb|4D83|C Chain C, Crystal Structure Of Human Beta Secretase In Complex
With Nvp-Bur436, Derived From A Co-Crystallization
Experiment
pdb|4D88|A Chain A, Crystal Structure Of Human Beta Secretase In Complex
With Nvp-Bxq490
pdb|4D89|A Chain A, Crystal Structure Of Human Beta Secretase In Complex
With Nvp-Bxd552, Derived From A Soaking Experiment
pdb|4D8C|A Chain A, Crystal Structure Of Human Beta Secretase In Complex
With Nvp-Bxd552, Derived From A Co-Crystallization
Experiment
pdb|4D8C|B Chain B, Crystal Structure Of Human Beta Secretase In Complex
With Nvp-Bxd552, Derived From A Co-Crystallization
Experiment
pdb|4D8C|C Chain C, Crystal Structure Of Human Beta Secretase In Complex
With Nvp-Bxd552, Derived From A Co-Crystallization
Experiment
Length = 402
Score = 26.6 bits (57), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 13 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 53
>pdb|1TQF|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Inhibitor
pdb|2B8L|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Inhibitor
pdb|2B8V|A Chain A, Crystal Structure Of Human Beta-Secretase Complexed With
L- L000430,469
pdb|2IRZ|A Chain A, Crystal Structure Of Human Beta-Secretase Complexed With
Inhibitor
pdb|2IS0|A Chain A, Crystal Structure Of Human Beta-Secretase Complexed With
Inhibitor
pdb|2PH6|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Inhibitor
pdb|2OAH|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Inhibitor
pdb|2P8H|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Inhibitor
pdb|2NTR|A Chain A, Crystal Structure Of Human Bace-1 Bound To Inhibitor
pdb|2PH8|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Inhibitor
pdb|2QZK|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
I21
pdb|2ZJM|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
N-[1-(5-Chloro-2-Isopropoxy-3-Methoxy-Benzyl)-
Piperidin-4-Yl]-2-(4-Sulfamoyl-Phenoxy)-Acetamide
pdb|3FKT|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Spiropiperdine Iminohydantoin Inhibitor
Length = 405
Score = 26.6 bits (57), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 17 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 57
>pdb|3TPJ|A Chain A, Apo Structure Of Bace1
pdb|3TPL|A Chain A, Apo Structure Of Bace1
pdb|3TPL|B Chain B, Apo Structure Of Bace1
pdb|3TPL|C Chain C, Apo Structure Of Bace1
pdb|3TPP|A Chain A, Crystal Structure Of Bace1 Complexed With An Inhibitor
pdb|3UQP|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|3UQU|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|3UQW|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|3UQX|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|4DV9|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|4DVF|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|4DVF|B Chain B, Crystal Structure Of Bace1 With Its Inhibitor
pdb|4FGX|A Chain A, Crystal Structure Of Bace1 With Novel Inhibitor
Length = 433
Score = 26.6 bits (57), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 37 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 77
>pdb|3R1G|B Chain B, Structure Basis Of Allosteric Inhibition Of Bace1 By An
Exosite- Binding Antibody
Length = 402
Score = 26.6 bits (57), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 4 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 44
>pdb|3CKP|A Chain A, Crystal Structure Of Bace-1 In Complex With Inhibitor
pdb|3CKP|B Chain B, Crystal Structure Of Bace-1 In Complex With Inhibitor
pdb|3CKP|C Chain C, Crystal Structure Of Bace-1 In Complex With Inhibitor
pdb|3CKR|A Chain A, Crystal Structure Of Bace-1 In Complex With Inhibitor
pdb|3CKR|B Chain B, Crystal Structure Of Bace-1 In Complex With Inhibitor
pdb|3CKR|C Chain C, Crystal Structure Of Bace-1 In Complex With Inhibitor
pdb|4FSL|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Db-Mut) Complex With N-(N-(4-
Acetamido-3-Chloro-5-Methylbenzyl) Carbamimidoyl)-3-(4-
Methoxyphenyl)-5-Methyl-4-Isothiazolecarboxamide
pdb|4FSL|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Db-Mut) Complex With N-(N-(4-
Acetamido-3-Chloro-5-Methylbenzyl) Carbamimidoyl)-3-(4-
Methoxyphenyl)-5-Methyl-4-Isothiazolecarboxamide
pdb|4FSL|D Chain D, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Db-Mut) Complex With N-(N-(4-
Acetamido-3-Chloro-5-Methylbenzyl) Carbamimidoyl)-3-(4-
Methoxyphenyl)-5-Methyl-4-Isothiazolecarboxamide
pdb|4FSL|E Chain E, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Db-Mut) Complex With N-(N-(4-
Acetamido-3-Chloro-5-Methylbenzyl) Carbamimidoyl)-3-(4-
Methoxyphenyl)-5-Methyl-4-Isothiazolecarboxamide
Length = 412
Score = 26.6 bits (57), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 16 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 56
>pdb|3L5J|A Chain A, Crystal Structure Of Fniii Domains Of Human Gp130 (Domains
4
pdb|3L5J|B Chain B, Crystal Structure Of Fniii Domains Of Human Gp130 (Domains
4
Length = 288
Score = 26.6 bits (57), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 13/44 (29%), Positives = 24/44 (54%)
Query: 55 AIITHYIVSYRDRTEDWQSVHVDAEYREFTLTQLKCGTHYKINI 98
I +Y + YR + +V+VD+ + E+TL+ L T Y + +
Sbjct: 227 GFIRNYTIFYRTIIGNETAVNVDSSHTEYTLSSLTSDTLYMVRM 270
>pdb|3KMX|A Chain A, Structure Of Bace Bound To Sch346572
pdb|3KMX|B Chain B, Structure Of Bace Bound To Sch346572
pdb|3KMY|A Chain A, Structure Of Bace Bound To Sch12472
pdb|3KMY|B Chain B, Structure Of Bace Bound To Sch12472
pdb|3KN0|A Chain A, Structure Of Bace Bound To Sch708236
pdb|3KN0|B Chain B, Structure Of Bace Bound To Sch708236
pdb|3LNK|A Chain A, Structure Of Bace Bound To Sch743813
pdb|3LNK|B Chain B, Structure Of Bace Bound To Sch743813
pdb|4FRS|A Chain A, Structure Of Bace In Complex With
(S)-4-(3-Chloro-5-(5-(Prop-1-Yn-1-
Yl)pyridin-3-Yl)thiophen-2-Yl)-1,
4-Dimethyl-6-Oxotetrahydropyrimidin- 2(1h)-Iminium
pdb|4FRS|B Chain B, Structure Of Bace In Complex With
(S)-4-(3-Chloro-5-(5-(Prop-1-Yn-1-
Yl)pyridin-3-Yl)thiophen-2-Yl)-1,
4-Dimethyl-6-Oxotetrahydropyrimidin- 2(1h)-Iminium
Length = 395
Score = 26.6 bits (57), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 6 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 46
>pdb|1YM4|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Nvp-Amk640
pdb|1YM4|B Chain B, Crystal Structure Of Human Beta Secretase Complexed With
Nvp-Amk640
pdb|1YM4|C Chain C, Crystal Structure Of Human Beta Secretase Complexed With
Nvp-Amk640
pdb|3K5D|A Chain A, Crystal Structure Of Bace-1 In Complex With Ahm178
pdb|3K5D|B Chain B, Crystal Structure Of Bace-1 In Complex With Ahm178
pdb|3K5D|C Chain C, Crystal Structure Of Bace-1 In Complex With Ahm178
pdb|3MSK|A Chain A, Fragment Based Discovery And Optimisation Of Bace-1
Inhibitors
pdb|3MSL|A Chain A, Fragment Based Discovery And Optimisation Of Bace-1
Inhibitors
pdb|3S2O|A Chain A, Fragment Based Discovery And Optimisation Of Bace-1
Inhibitors
pdb|4D85|A Chain A, Crystal Structure Of Human Beta Secretase In Complex
With Nvp-Bvi151
Length = 408
Score = 26.6 bits (57), Expect = 8.6, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 13 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 53
>pdb|1W50|A Chain A, Apo Structure Of Bace (beta Secretase)
pdb|1W51|A Chain A, Bace (Beta Secretase) In Complex With A Nanomolar Non-
Peptidic Inhibitor
pdb|3RSV|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
(R)-3-(2-Amino-6-
O-Tolylquinolin-3-Yl)-N-((R)-2,
2-Dimethyltetrahydro-2h-Pyran-4-Yl)-2-
Methylpropanamide
pdb|3RSX|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
6-(Thiophen-3- Yl)quinolin-2-Amine
pdb|3RTH|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
6-(2-(3,3- Dimethylbut-1-Ynyl)phenyl)quinolin-2-Amine
pdb|3RTM|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
3-(2-
Aminoquinolin-3-Yl)-N-Cyclohexyl-N-Methylpropanamide
pdb|3RTN|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
3-(2-Amino-6-O-
Tolylquinolin-3-Yl)-N-Cyclohexylpropanamide
pdb|3RU1|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
3-(2-
Aminoquinolin-3-Yl)-N-(Cyclohexylmethyl)propanamide
pdb|3RVI|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
2-((2-Amino-6-O-
Tolylquinolin-3-Yl)methyl)-N-
(Cyclohexylmethyl)pentanamide
pdb|4ACU|A Chain A, Aminoimidazoles As Bace-1 Inhibitors. X-Ray Crystal
Structure Of Beta Secretase Complexed With Compound 14
pdb|4ACX|A Chain A, Aminoimidazoles As Bace-1 Inhibitors. X-Ray Crystal
Structure Of Beta Secretase Complexed With Compound 23
pdb|4DH6|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
(2r)-N-((2s,3r)-
1-(Benzo[d][1,
3]dioxol-5-Yl)-3-Hydroxy-4-((S)-6'-Neopentyl-3',4'-
Dihydrospiro[cyclobutane-1,2'-Pyrano[2,
3-B]pyridine]-4'-Ylamino)
Butan-2-Yl)-2-Methoxypropanamide
pdb|4FRI|A Chain A, Crystal Structure Of Bace1 In Complex With Biarylspiro
Aminooxazoline 6
pdb|4FRJ|A Chain A, Crystal Structure Of Bace1 In Complex With
Aminooxazoline Xanthene 9l
pdb|4FRK|A Chain A, Crystal Structure Of Bace1 In Complex With
Aminooxazoline Xanthene 11a
pdb|4DI2|A Chain A, Crystal Structure Of Bace1 In Complex With
Hydroxyethylamine Inhibitor 37
pdb|4DI2|B Chain B, Crystal Structure Of Bace1 In Complex With
Hydroxyethylamine Inhibitor 37
pdb|4DI2|C Chain C, Crystal Structure Of Bace1 In Complex With
Hydroxyethylamine Inhibitor 37
pdb|4DUS|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
N-((2s,3r)-1-(4-
Fluorophenyl)-3-Hydroxy-4-((6'-Neopentyl-3',4'-
Dihydrospiro[cyclobutane-1,2'-Pyrano[2,
3-B]pyridin]-4'-Yl)amino) Butan-2-Yl)acetamide
pdb|4AZY|A Chain A, Design And Synthesis Of Bace1 Inhibitors With In Vivo
Brain Reduction Of Beta-Amyloid Peptides (Compound 10)
pdb|4B00|A Chain A, Design And Synthesis Of Bace1 Inhibitors With In Vivo
Brain Reduction Of Beta-Amyloid Peptides (Compound
(R)-41)
pdb|4B05|A Chain A, Preclinical Characterization Of Azd3839, A Novel
Clinical Candidate Bace1 Inhibitor For The Treatment Of
Alzheimer Disease
Length = 411
Score = 26.6 bits (57), Expect = 8.6, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 16 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 56
>pdb|3TPR|A Chain A, Crystal Structure Of Bace1 Complexed With An Inhibitor
pdb|3UQR|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|3UQR|B Chain B, Crystal Structure Of Bace1 With Its Inhibitor
pdb|3UQR|C Chain C, Crystal Structure Of Bace1 With Its Inhibitor
Length = 433
Score = 26.6 bits (57), Expect = 8.6, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 37 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 77
>pdb|3U6A|A Chain A, Rational Design And Synthesis Of Aminopiperazinones As
Beta Secretase (Bace) Inhibitors
pdb|3U6A|B Chain B, Rational Design And Synthesis Of Aminopiperazinones As
Beta Secretase (Bace) Inhibitors
pdb|3U6A|C Chain C, Rational Design And Synthesis Of Aminopiperazinones As
Beta Secretase (Bace) Inhibitors
Length = 390
Score = 26.6 bits (57), Expect = 8.6, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 2 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 42
>pdb|3EXO|A Chain A, Crystal Structure Of Bace1 Bound To Inhibitor
Length = 413
Score = 26.6 bits (57), Expect = 8.7, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 17 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 57
>pdb|3UDH|A Chain A, Crystal Structure Of Bace With Compound 1
pdb|3UDJ|A Chain A, Crystal Structure Of Bace With Compound 5
pdb|3UDK|A Chain A, Crystal Structure Of Bace With Compound 6
pdb|3UDM|A Chain A, Crystal Structure Of Bace With Compound 8
pdb|3UDN|A Chain A, Crystal Structure Of Bace With Compound 9
pdb|3UDP|A Chain A, Crystal Structure Of Bace With Compound 12
pdb|3UDQ|A Chain A, Crystal Structure Of Bace With Compound 13
pdb|3UDR|A Chain A, Crystal Structure Of Bace With Compound 14
pdb|3UDY|A Chain A, Crystal Structure Of Bace With Compound 11
pdb|4FM7|A Chain A, Crystal Structure Of Bace With Compound 14g
pdb|4FM8|A Chain A, Crystal Structure Of Bace With Compound 12a
Length = 404
Score = 26.6 bits (57), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 1 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 41
>pdb|3QI1|A Chain A, Design And Synthesis Of Hydroxyethylamine (Hea) Bace-1
Inhibitors: Prime Side Chromane-Containing Inhibitors
Length = 408
Score = 26.6 bits (57), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 13 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 53
>pdb|2ZJK|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
4-(4-Fluoro-Benzyl)-Piperazine-2-Carboxylic
Acid(3-Mercapto-Propyl)-Amide
pdb|2ZJK|B Chain B, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
4-(4-Fluoro-Benzyl)-Piperazine-2-Carboxylic
Acid(3-Mercapto-Propyl)-Amide
pdb|2ZJK|C Chain C, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
4-(4-Fluoro-Benzyl)-Piperazine-2-Carboxylic
Acid(3-Mercapto-Propyl)-Amide
Length = 405
Score = 26.6 bits (57), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 17 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 57
>pdb|2ZJI|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
N-[1-(2,
6-Dimethoxy-Benzyl)-Piperidin-4-Yl]-4-Mercapto-
Butyramide
Length = 405
Score = 26.6 bits (57), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 17 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 57
>pdb|2ZJH|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
N-(1-Benzyl-Piperidin-4-Yl)-4-Mercapto-Butyramide
pdb|2ZJL|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
N-[1-(5-Bromo-2,3-Dimethoxy-Benzyl)-Piperidin-
4-Yl]-4-Mercapto-Butyramide
Length = 405
Score = 26.6 bits (57), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 17 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 57
>pdb|3HVG|A Chain A, Structure Of Bace (Beta Secretase) In Complex With Ev0
pdb|3HVG|B Chain B, Structure Of Bace (Beta Secretase) In Complex With Ev0
pdb|3HVG|C Chain C, Structure Of Bace (Beta Secretase) In Complex With Ev0
pdb|3HW1|A Chain A, Structure Of Bace (Beta Secretase) In Complex With
Ligand Ev2
pdb|3HW1|B Chain B, Structure Of Bace (Beta Secretase) In Complex With
Ligand Ev2
pdb|3HW1|C Chain C, Structure Of Bace (Beta Secretase) In Complex With
Ligand Ev2
pdb|3MSJ|A Chain A, Structure Of Bace (Beta Secretase) In Complex With
Inhibitor
pdb|3MSJ|B Chain B, Structure Of Bace (Beta Secretase) In Complex With
Inhibitor
pdb|3MSJ|C Chain C, Structure Of Bace (Beta Secretase) In Complex With
Inhibitor
Length = 411
Score = 26.6 bits (57), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 16 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 56
>pdb|2EE2|A Chain A, Solution Structures Of The Fn3 Domain Of Human Contactin 1
Length = 119
Score = 26.6 bits (57), Expect = 9.0, Method: Compositional matrix adjust.
Identities = 11/21 (52%), Positives = 15/21 (71%)
Query: 143 IENLLPATRYELTISAKNDAG 163
+ENLLP T+Y + + A N AG
Sbjct: 78 LENLLPDTQYFIEVGACNSAG 98
>pdb|2ZJJ|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
4-(4-Fluoro-Benzyl)-Piperazine-2-Carboxylic Acid
(2-Mercapto-Ethyl)- Amide
Length = 405
Score = 26.6 bits (57), Expect = 9.0, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 17 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 57
>pdb|3CIB|A Chain A, Structure Of Bace Bound To Sch727596
pdb|3CIB|B Chain B, Structure Of Bace Bound To Sch727596
pdb|3CIC|A Chain A, Structure Of Bace Bound To Sch709583
pdb|3CIC|B Chain B, Structure Of Bace Bound To Sch709583
pdb|3CID|A Chain A, Structure Of Bace Bound To Sch726222
pdb|3CID|B Chain B, Structure Of Bace Bound To Sch726222
pdb|4FS4|A Chain A, Structure Of Bace Bound To
(S)-4-(3'-Methoxy-[1,1'-Biphenyl]-3-Yl)-1,
4-Dimethyl-6-Oxotetrahydropyrimidin-2(1h)-Iminium
pdb|4FS4|B Chain B, Structure Of Bace Bound To
(S)-4-(3'-Methoxy-[1,1'-Biphenyl]-3-Yl)-1,
4-Dimethyl-6-Oxotetrahydropyrimidin-2(1h)-Iminium
Length = 390
Score = 26.6 bits (57), Expect = 9.0, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 1 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 41
>pdb|1SGZ|A Chain A, Crystal Structure Of Unbound Beta-Secretase Catalytic
Domain.
pdb|1SGZ|B Chain B, Crystal Structure Of Unbound Beta-Secretase Catalytic
Domain.
pdb|1SGZ|C Chain C, Crystal Structure Of Unbound Beta-Secretase Catalytic
Domain.
pdb|1SGZ|D Chain D, Crystal Structure Of Unbound Beta-Secretase Catalytic
Domain.
pdb|1XS7|D Chain D, Crystal Structure Of A Cycloamide-Urethane-Derived Novel
Inhibitor Bound To Human Brain Memapsin 2
(Beta-Secretase).
pdb|1XN2|A Chain A, New Substrate Binding Pockets For Beta-Secretase.
pdb|1XN2|B Chain B, New Substrate Binding Pockets For Beta-Secretase.
pdb|1XN2|C Chain C, New Substrate Binding Pockets For Beta-Secretase.
pdb|1XN2|D Chain D, New Substrate Binding Pockets For Beta-Secretase.
pdb|1XN3|A Chain A, Crystal Structure Of Beta-Secretase Bound To A Long
Inhibitor With Additional Upstream Residues.
pdb|1XN3|B Chain B, Crystal Structure Of Beta-Secretase Bound To A Long
Inhibitor With Additional Upstream Residues.
pdb|1XN3|C Chain C, Crystal Structure Of Beta-Secretase Bound To A Long
Inhibitor With Additional Upstream Residues.
pdb|1XN3|D Chain D, Crystal Structure Of Beta-Secretase Bound To A Long
Inhibitor With Additional Upstream Residues.
pdb|2G94|A Chain A, Crystal Structure Of Beta-secretase Bound To A Potent
And Highly Selective Inhibitor.
pdb|2G94|B Chain B, Crystal Structure Of Beta-secretase Bound To A Potent
And Highly Selective Inhibitor.
pdb|2G94|C Chain C, Crystal Structure Of Beta-secretase Bound To A Potent
And Highly Selective Inhibitor.
pdb|2G94|D Chain D, Crystal Structure Of Beta-secretase Bound To A Potent
And Highly Selective Inhibitor.
pdb|2P4J|A Chain A, Crystal Structure Of Beta-Secretase Bond To An Inhibitor
With Isophthalamide Derivatives At P2-P3
pdb|2P4J|B Chain B, Crystal Structure Of Beta-Secretase Bond To An Inhibitor
With Isophthalamide Derivatives At P2-P3
pdb|2P4J|C Chain C, Crystal Structure Of Beta-Secretase Bond To An Inhibitor
With Isophthalamide Derivatives At P2-P3
pdb|2P4J|D Chain D, Crystal Structure Of Beta-Secretase Bond To An Inhibitor
With Isophthalamide Derivatives At P2-P3
pdb|2VKM|A Chain A, Crystal Structure Of Grl-8234 Bound To Bace
(Beta-Secretase)
pdb|2VKM|B Chain B, Crystal Structure Of Grl-8234 Bound To Bace
(Beta-Secretase)
pdb|2VKM|C Chain C, Crystal Structure Of Grl-8234 Bound To Bace
(Beta-Secretase)
pdb|2VKM|D Chain D, Crystal Structure Of Grl-8234 Bound To Bace
(Beta-Secretase)
pdb|3UFL|A Chain A, Discovery Of Pyrrolidine-Based B-Secretase Inhibitors:
Lead Advancement Through Conformational Design For
Maintenance Of Ligand Binding Efficiency
Length = 389
Score = 26.6 bits (57), Expect = 9.1, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 1 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 41
>pdb|4B1C|A Chain A, New Aminoimidazoles As Bace-1 Inhibitors: From Rational
Design To Ab-Lowering In Brain
Length = 375
Score = 26.6 bits (57), Expect = 9.1, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 3 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 43
>pdb|3OJV|C Chain C, Crystal Structure Of Fgf1 Complexed With The Ectodomain Of
Fgfr1c Exhibiting An Ordered Ligand
Specificity-Determining Betac'-Betae Loop
pdb|3OJV|D Chain D, Crystal Structure Of Fgf1 Complexed With The Ectodomain Of
Fgfr1c Exhibiting An Ordered Ligand
Specificity-Determining Betac'-Betae Loop
Length = 226
Score = 26.6 bits (57), Expect = 9.1, Method: Compositional matrix adjust.
Identities = 9/23 (39%), Positives = 16/23 (69%)
Query: 3 GNYTCLADNIFGKDDIYYQVTIL 25
GNYTC+ +N +G + YQ+ ++
Sbjct: 87 GNYTCIVENEYGSINHTYQLDVV 109
>pdb|3D1M|C Chain C, Crystal Structure Of Sonic Hedgehog Bound To The Third
Fniii Domain Of Cdo
pdb|3D1M|D Chain D, Crystal Structure Of Sonic Hedgehog Bound To The Third
Fniii Domain Of Cdo
pdb|3N1F|C Chain C, Crystal Structure Of Ihhn Bound To Cdofn3
pdb|3N1F|D Chain D, Crystal Structure Of Ihhn Bound To Cdofn3
pdb|3N1Q|C Chain C, Crystal Structure Of Dhhn Bound To Cdofn3
pdb|3N1Q|D Chain D, Crystal Structure Of Dhhn Bound To Cdofn3
pdb|3N1Q|F Chain F, Crystal Structure Of Dhhn Bound To Cdofn3
Length = 102
Score = 26.6 bits (57), Expect = 9.1, Method: Compositional matrix adjust.
Identities = 19/74 (25%), Positives = 32/74 (43%), Gaps = 4/74 (5%)
Query: 49 PSYDGGAIITHYIVSYR----DRTEDWQSVHVDAEYREFTLTQLKCGTHYKINIKLVNSI 104
PS + I + + YR D D++ V+ + + L+ T Y I ++ N
Sbjct: 29 PSSNNNTPIQGFYIYYRPTDSDNDSDYKRDVVEGSKQWHMIGHLQPETSYDIKMQCFNEG 88
Query: 105 GESKPSKTIAASTK 118
GES+ S + TK
Sbjct: 89 GESEFSNVMICETK 102
>pdb|2WJO|A Chain A, Human Bace (Beta Secretase) In Complex With
Cyclohexanecarboxylic Acid (2-(2-Am Ino-6-Phenoxy-4h-
Quinazolin-3-Yl)-2-Cyclohexyl-Ethyl)-Amide
Length = 412
Score = 26.6 bits (57), Expect = 9.2, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 1 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 41
>pdb|1CVS|C Chain C, Crystal Structure Of A Dimeric Fgf2-Fgfr1 Complex
pdb|1CVS|D Chain D, Crystal Structure Of A Dimeric Fgf2-Fgfr1 Complex
pdb|1FQ9|C Chain C, Crystal Structure Of A Ternary Fgf2-Fgfr1-Heparin Complex
pdb|1FQ9|D Chain D, Crystal Structure Of A Ternary Fgf2-Fgfr1-Heparin Complex
Length = 225
Score = 26.6 bits (57), Expect = 9.2, Method: Compositional matrix adjust.
Identities = 9/23 (39%), Positives = 16/23 (69%)
Query: 3 GNYTCLADNIFGKDDIYYQVTIL 25
GNYTC+ +N +G + YQ+ ++
Sbjct: 86 GNYTCIVENEYGSINHTYQLDVV 108
>pdb|4B1D|A Chain A, New Aminoimidazoles As Bace-1 Inhibitors: From Rational
Design To Ab-Lowering In Brain
pdb|4B1E|A Chain A, New Aminoimidazoles As Bace-1 Inhibitors: From Rational
Design To Ab-Lowering In Brain
Length = 388
Score = 26.6 bits (57), Expect = 9.3, Method: Compositional matrix adjust.
Identities = 13/41 (31%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 3 GNYTCLADNIFGK--DDIYYQVTILSPPGVPNILLQSTTTH 41
G++ + DN+ GK Y ++T+ SPP NIL+ + +++
Sbjct: 1 GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSN 41
>pdb|1NI7|A Chain A, Northeast Structural Genomic Consortium Target Er75
Length = 155
Score = 26.6 bits (57), Expect = 9.4, Method: Compositional matrix adjust.
Identities = 16/54 (29%), Positives = 27/54 (50%)
Query: 129 PLSNLDEALEMPLVIENLLPATRYELTISAKNDAGSTNKNYVFATLSVNGGKAF 182
PL+ ++ +++ LPA EL AK AG N+ ++ T++ NG F
Sbjct: 26 PLTQWEDKYRQLIMLGKQLPALPDELKAQAKEIAGCENRVWLGYTVAENGKMHF 79
>pdb|1EVT|C Chain C, Crystal Structure Of Fgf1 In Complex With The
Extracellular Ligand Binding Domain Of Fgf Receptor 1
(Fgfr1)
pdb|1EVT|D Chain D, Crystal Structure Of Fgf1 In Complex With The
Extracellular Ligand Binding Domain Of Fgf Receptor 1
(Fgfr1)
Length = 225
Score = 26.6 bits (57), Expect = 9.4, Method: Compositional matrix adjust.
Identities = 9/23 (39%), Positives = 16/23 (69%)
Query: 3 GNYTCLADNIFGKDDIYYQVTIL 25
GNYTC+ +N +G + YQ+ ++
Sbjct: 86 GNYTCIVENEYGSINHTYQLDVV 108
>pdb|3L5H|A Chain A, Crystal Structure Of The Full Ectodomain Of Human Gp130:
New Insights Into The Molecular Assembly Of Receptor
Complexes
Length = 589
Score = 26.6 bits (57), Expect = 9.6, Method: Compositional matrix adjust.
Identities = 13/44 (29%), Positives = 24/44 (54%)
Query: 55 AIITHYIVSYRDRTEDWQSVHVDAEYREFTLTQLKCGTHYKINI 98
I +Y + YR + +V+VD+ + E+TL+ L T Y + +
Sbjct: 526 GFIRNYTIFYRTIIGNETAVNVDSSHTEYTLSSLTSDTLYMVRM 569
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.315 0.132 0.393
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 6,259,288
Number of Sequences: 62578
Number of extensions: 249442
Number of successful extensions: 769
Number of sequences better than 100.0: 107
Number of HSP's better than 100.0 without gapping: 36
Number of HSP's successfully gapped in prelim test: 71
Number of HSP's that attempted gapping in prelim test: 693
Number of HSP's gapped (non-prelim): 137
length of query: 197
length of database: 14,973,337
effective HSP length: 94
effective length of query: 103
effective length of database: 9,091,005
effective search space: 936373515
effective search space used: 936373515
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 49 (23.5 bits)